Restoring dignity: Senegalese surgeon and Burundian foundation win reproductive health awards
The UN sexual and reproductive health agency, UNFPA, announced on Wednesday that the individual award will go to Professor Serigne…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
Employers Are Not Expanding Coverage of GLP-1 Anti-Obesity Drugs: Survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
They harvest the country's food, but a new rule could strip them of health insurance
Seasonal work. Inconsistent schedules. Frequent movements. Cash payments and informal jobs. For farmworkers who rely on Medicaid, these common employment…
World must accelerate Ebola response in DR Congo: UN aid chief
Fletcher warned that while Ituri province remains the center of the outbreak, the virus is spreading to other provinces due…
AstraZeneca trial failure raises bigger questions about its portfolio
AstraZenecaWainua's failed final trial was never expected to have a major financial impact on the company. Most analysts estimate that…
Journalists debate raw milk marketing, extreme heat and spending on opioid deals
Céline Gounder, public health editor-at-large for KFF Health News, discussed the health risks of consuming raw milk and an outbreak…
New cholera outbreak alert for war-weary Sudanese communities
“Cholera has returned and affects several statesmainly in the western part of the country, Darfur and Kordofan,” said Dr. Shible…
Abivax receives $920 million in cash to prepare for US launch: CEO
AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…
Cancer cases could almost double by 2050 if urgent action is not taken, warns WHO
That's the headline emerging from a new report from the UN health agency that highlights stark inequalities in cancer survival…
AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…